When:
Tuesday, April 2, 2024 - 12:00am
Cumulus Oncology is developing anti‑cancer therapies for clinical settings in areas of high unmet need, with the aim of developing improved outcomes for cancer patients. In particular, the company is interested in the identification of specific molecular targets and biomarkers associated with ferroptosis, which allow for the development of targeted therapies.